Endocannabinoids control spasticity in a multiple sclerosis model. by Baker, D, Pryce, G, Croxford, J, Brown, P, Pertwee, R, Makriyannis, A, Khanolkar, A, Layward, L, Fezza, F, Bisogno, T, Di Marzo, V

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) recepto... by Brooks, J, Pryce, G, Bisogno, T, Jaggar, S, Hankey, D, Brown, P, Bridges, D, Ledent, C, Bifulco, M, Rice, A, Di Marzo, V, Baker, D